Tamoxifen in Women With Breast Cancer and in Women at High-Risk of Breast Cancer Who Are Receiving Venlafaxine, Citalopram, Escitalopram, Gabapentin, or Sertraline
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Depression|Hot Flashes|Psychosocial Effects of Cancer and Its Treatment
Interventions: DRUG: citalopram hydrobromide|DRUG: escitalopram oxalate|DRUG: gabapentin|DRUG: sertraline hydrochloride|DRUG: tamoxifen citrate|DRUG: venlafaxine|GENETIC: molecular genetic technique|OTHER: high performance liquid chromatography|OTHER: laboratory biomarker analysis|OTHER: pharmacological study|PROCEDURE: adjuvant therapy
Sponsor: Mayo Clinic
Collaborators: National Cancer Institute (NCI)